21. The efficacy and safety of macitentan in Fontan-palliated patients: results of the 52-week randomised, placebo-controlled RUBATO trial. (3rd October 2022) Authors: Clift, P; Berger, F; Sondergaard, L; Antonova, P; Disney, P; Nicolarsen, J; Thambo, J B; Tomkiewicz Pajak, L; Wang, J K; Schophuus Jensen, A; Burgess, G; Efficace, M; Friberg, M; Lassen, C; d'Udekem, Y Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
22. Transition for patients with congenital heart disease in the UK: need for a universal model with adequate training and support. (25th November 2020) Authors: Krishnathasan, K; Constantine, A; Fitzsimmons, S; Taliotis, D; Bedair, R; Curtis, S; Frigiola, A; Orchard, E; Pandya, B; Lockhart, C.J; Clift, P; Hudsmith, L; Oliver, J; Papaioannou, V; Dimopoulos, K Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
23. YI-4 Non invasive assessment of pulmonary capacitance in the fontan patient correlates with functional class and peak oxygen consumption. (2nd March 2016) Authors: Luke, Louis; Rutter, Luke; Bowater, S; Hudsmith, L; Thorne, S; Clift, P Journal: Heart Issue: Volume 102(2016)Supplement 1 Page Start: A27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗